Human cytomegalovirus (HCMV) is a major cause of morbidity and mortality in transplant patients and the leading viral cause of birth defects after congenital infection. The glycoprotein complexes gH/gL/gO and gH/gL/UL128/UL130/UL131A (Pentamer) are key targets of the human humoral response against HCMV and are required for HCMV entry into fibroblasts and endothelial/epithelial cells, respectively. We expressed and characterized soluble forms of gH/gL, gH/gL/gO, and Pentamer. Mass spectrometry and mutagenesis analysis revealed that gL-Cys144 forms disulfide bonds with gO-Cys351 in gH/gL/gO and with UL128-Cys162 in the Pentamer. Notably, Pentamer harboring the UL128-Cys162Ser/gL-Cys144Ser mutations had impaired syncytia formation and reduced interference of HCMV entry into epithelial cells. Electron microscopy analysis showed that HCMV gH/gL resembles HSV gH/gL and that gO and UL128/UL130/UL131A bind to the same site at the gH/gL N terminus. These data are consistent with gH/gL/gO and Pentamer forming mutually exclusive cell entry complexes and reveal the overall location of gH/gL-, gH/gL/ gO-, and Pentamer-specific neutralizing antibody binding sites. Our results provide, to our knowledge, the first structural view of gH/gL/ gO and Pentamer supporting the development of vaccines and antibody therapeutics against HCMV.
H uman cytomegalovirus (HCMV) is a member of the β-herpesvirus subfamily with >60% seropositivity in adults worldwide (1) . HCMV infection is typically asymptomatic, but can cause severe disease or death in immunocompromised solid organ and hematopoietic stem cell transplant recipients. In addition, HCMV can infect the placenta and cross this barrier to infect developing fetuses, causing severe birth defects (2) . Given the severity and importance of this disease, obtaining an effective vaccine is considered a public health priority (3) .
The ability of HCMV to cause disease in a wide range of organs and tissue types is reflected at the cellular level by the virus infecting epithelial cells, endothelial cells, fibroblasts, dendritic cells, hepatocytes, neurons, macrophages, and leukocytes (4) . Similar to other herpesviruses, the envelope glycoproteins gB and gH/gL form the conserved fusion machinery required for viral entry (5, 6) . Recent structural and mutagenesis analysis suggested that gB is responsible for mediating virus and host membrane fusion during viral entry (7, 8) . The role of gH/gL in fusion is less clear because crystal structures of herpes simplex virus 2 (HSV-2), pseudo-rabies virus (PrV), and Epstein-Barr virus (EBV) gH/gL did not reveal any similarity to known viral fusion proteins (9) (10) (11) . It has been proposed that gH/gL is involved in the entry process through activation of gB (12) . In addition to gB and gH/gL, most herpesviruses encode additional glycoproteins that are able to interact with gH/gL and are capable of either mediating binding to specific cellular receptors or regulating the activity of the gH/gL-gB complex (5, 6) .
HCMV entry into both epithelial and endothelial cells requires a pentameric glycoprotein complex (Pentamer) formed between gH/gL and the UL128, UL130, and UL131A proteins (13, 14) . Mutations in the UL131A-UL128 gene locus are sufficient to eliminate epithelial/endothelial tropism and occur spontaneously within only a few passages of wild-type (WT) HCMV in fibroblasts (15, 16) . In addition, Pentamer cell surface overexpression interferes with HCMV entry into epithelial cells, but not into fibroblasts, suggesting the presence of a cell-typespecific Pentamer receptor (17) .
HCMV entry into fibroblasts is mediated by the gH/gL/gO complex at the cell surface at neutral pH (18) (19) (20) (21) . gO is a highly glycosylated protein and has been shown to covalently interact with gH/gL (22, 23) . It has been proposed that gO might function as a molecular chaperone to promote gH/gL incorporation, but not gH/gL/gO, into the virion (21) . However, it has been recently Significance Human cytomegalovirus (HCMV) is a major cause of morbidity and mortality in transplant patients and in fetuses after congenital infection. gH/gL/gO and Pentamer are targets for neutralizing antibodies. We show that gO and UL128/UL130/ UL131A bind to the same site on gH/gL through formation of a disulfide bond with gL-Cys144. The alternative use of this binding site by either gO or the ULs may provide a mechanism for cell tropism modulation. Our analysis reveals that gH/gL antigenic sites are conserved among gH/gL, gH/gL/gO, and Pentamer, whereas gH/gL/gO-and Pentamer-specific neutralizing antibody-binding sites are located in the gH/gL N terminus protrusion that contains the gO and the UL subunits. These data support the development of vaccines and antibody therapeutics against HCMV.
demonstrated that gH/gL/gO and Pentamer are much more abundant on the HCMV envelope than gH/gL alone (24) .
Highly potent HCMV-neutralizing monoclonal antibodies were isolated from the memory B-cell repertoire of HCMVimmune donors and shown to bind the Pentamer. These antibodies were capable of neutralizing HCMV infection of epithelial/endothelial cells, but not fibroblasts (25, 26) . In addition, several studies have demonstrated that the Pentamer is the main target of the neutralizing humoral response to HCMV infection in epithelial/endothelial cells (27) (28) (29) . Consistent with these observations, immunization with the Pentamer has been shown to elicit a strong neutralizing antibody response in mouse, rabbit, and rhesus macaque models (30) (31) (32) . Together these data indicate that the Pentamer represents a key antigenic target for vaccine development against HCMV infection.
Here we report the purification and biochemical characterization of HCMV gH/gL, gH/gL/gO, and Pentamer. In addition, we describe the architecture of these complexes by electron microscopy (EM) and characterize their interaction with MSL-109, a previously described HCMV-neutralizing antibody isolated from the spleen of a HCMV-seropositive individual (33, 34) . Our data provide new insights into the structure and function of the HCMV gH/gL/gO and Pentamer complexes. Bridges. To investigate the architecture of HCMV gH/gL, gH/gL/ gO, and Pentamer, we reconstituted each complex by transiently transfecting HEK293 cells with plasmids expressing the individual components (Fig. S1 ). Protein complexes were purified from the cell medium by affinity followed by size-exclusion chromatography (SEC) and then analyzed by SDS/PAGE (SI Materials and Methods; Fig. 1 ). Consistent with previous reports (24, 32, 35, 36) , this analysis revealed that HCMV gH and gL are covalently linked by disulfide bonds and that additional disulfides form between two gH/gL complexes. For simplicity, these dimers of gH/gL heterodimers will be referred to as gH/gL homodimers (Fig. 1A) .
The gH/gL/gO complex migrated in SEC with an apparent molecular weight of ∼220 kDa, consistent with the theoretical molecular weight of a 1:1:1 complex (Fig. 1B) . The complex disassembled completely only upon addition of reducing agents, supporting a role of disulfide bridges in stabilization (Fig. 1B) . Importantly, the gOcontaining complex did not dimerize, suggesting that gO interferes with the gH/gL propensity to homodimerize.
Finally, coexpression of gH, gL, UL128, UL130, and UL131A generated a stable complex migrating in SEC with an apparent molecular mass of ∼180 kDa (Fig. 1C) , suggesting the presence of one copy for each of the components of the complex. SDS/PAGE under boiling conditions showed that gH/gL and UL128 are covalently linked, and reducing agent addition dissociated the complex. Similar to gO, UL128/UL130/UL131A (from now on referred to as ULs) interfered with gH/gL homodimerization. Formation of disulfide-linked gH/gL/gO and gH/gL/UL128 complexes was previously suggested from coimmunoprecipitation experiments using gO-and UL128-specific antibodies, respectively (23).
gL-Cys-144 Forms a Disulfide Bond with gO-Cys-351 and UL128-Cys-162. We used mass spectrometry (MS) to investigate which cysteines are involved in disulfide formation (SI Results). Analysis of gH/gL showed that gL-Cys-144 on one monomer forms a disulfide bridge with gL-Cys-144 on a second monomer, demonstrating that the gL subunit is involved in homodimerization (Fig.  S2A ). To confirm this finding, we reconstituted a gH/gL complex carrying a Cys-144-Ser mutation. The purified complex appears to be monomeric as revealed by SDS/PAGE ( Fig. 2A ) and SEC. In addition, MS analysis identified a disulfide bond between gLCys-47 and gH-Cys-95 (Fig. S2B) , consistent with the covalent interaction between gH and gL. Mutation of either cysteine prevented gH/gL secretion, suggesting that this disulfide is essential for gH/gL complex folding (Fig. S3 ).
MS analysis of gH/gL/gO showed that gL-Cys-144 forms a disulfide bond with gO-Cys-351 (Fig. S2C) . We also detected an alternative disulfide bond between gL-Cys-144 and gO-Cys-226 (Fig. S2D) . Reconstitution of gH/gL/gO carrying the gL-Cys-144-Ser point mutation resulted in lack of covalent interaction between gO and gH/gL (Fig. 2B ), in agreement with the MS data. The gO-Cys351Ser mutation impaired gO expression resulting in secretion of gH/gL only (Fig. S4) .
Finally, MS analysis of the Pentamer showed that gL-Cys-144 forms a disulfide bond with UL128-Cys-162 (Fig. S2E) . SDS/ PAGE analysis of Pentamer carrying the gL-Cys-144-Ser or Fig. 1 . Analyses of gH/gL, gH/gL/gO, and Pentamer complexes. (A) SEC of affinity-purified gH/gL shows two peaks indicative of gH/gL homodimer and gH/gL monomer. SDS/PAGE analysis shows that DTT is required to completely disrupt the gH/gL homodimer, suggesting that disulfide bonds may cross-link two gH/gL heterodimers. (B) SEC of affinity-purified gH/gL/gO shows one major peak. Both heat and DTT are needed to dissociate the gH/gL/gO complex into gH, gL, and gO. (C) SEC of Pentamer shows one peak. SDS/PAGE has three distinct bands: one composed of gH/gL/UL128 held together by internal disulfide bonds and two others composed of either UL130 or UL131A. Heat and reducing agents disrupt gH/gL/UL128 and free UL128 has a similar size to UL131A. Individual protein identity was confirmed by N-terminal sequencing.
UL128-Cys-162-Ser revealed a lack of covalent interaction between gH/gL and UL128 (Fig. 2C) . Therefore, the same cysteine in gL, gL-Cys-144, forms alternative disulfide bonds with gO and UL128 and, in their absence, is available to form disulfide linked gH/gL homodimers.
Effects of UL128-Cys-162 and/or gL-Cys-144 Mutations on Pentamer
Function. To investigate the role of the disulfide bond between gL-Cys-144 and UL128-Cys-162 in HCMV infection we assessed the effect of the single and double Cys→Ser mutations in Pentamer-mediated interference of viral entry in adult retinal pigment epithelial 19 (ARPE-19) cells (17, 21) . Cells were transduced with adenoviruses (AdVs) expressing the full-length Pentamer proteins, followed by infection with HCMV (lowpassage HCMV clinical isolate VR1814). In this assay, Pentamer can bind and sequester host molecules required for viral entry, thus protecting cells from HCMV infection (17) . VR1814 has an accelerated viral gene expression profile compared with various other clinical isolates and laboratory strains tested (34) . WT Pentamer overexpression protected >80% of cells from infection, compared with cells transduced with the LacZ control or gB-gH/ gL ( Fig. 3A ; paired t test; P = 0.0012). In contrast, cells expressing gH/gL-Cys-144-Ser/UL128/UL130/UL131A (gL-Cys-144-Ser) or gH/gL/UL128-Cys-162-Ser/UL130/UL131A (UL128-Cys-162-Ser) were partially permissive for VR1814 infection, as revealed by expression of HCMV immediate early genes 24 h after infection (P = 0.0081 and 0.0251). Moreover, gH/gL-Cys-144-Ser/UL128-Cys-162-Ser/UL130/UL131A (gL-Cys-144-Ser/ UL128-Cys-162-Ser) overexpression did not interfere with HCMV infection, indicating that the mutations functionally impaired the ability of the Pentamer to compete with the native complex found on virions during virus entry ( Fig. 3A ; P = 0.4520).
The same mutants were tested in a syncytia assay in ARPE-19 cells. Coexpression of the full-length VR1814 WT gB and Pentamer resulted in syncytia formation of nearly all cells (Fig. 3B) , whereas gL-Cys-144-Ser or UL128-Cys-162-Ser did not affect cell-to-cell fusion. Of note, we detected a small, but reproducible, delay in syncytia formation for UL128-Cys-162-Ser that nevertheless induced cell fusion comparable to WT 30 h after transduction (Fig. 3B) . Strikingly, gL-Cys-144-Ser/UL128-Cys-162-Ser was not able to induce epithelial cell fusion (Fig. 3B, bottom row) .
We next assessed whether Pentamer mutants expressed on the cell surface could be recognized by MSL-109, a gH-specific monoclonal antibody (33, 34); 10P3, a monoclonal antibody recognizing UL130/UL131A as part of correctly assembled Pentamer (26); and Cytotect, human IgGs from HCMV-positive individuals that contain a high fraction of Pentamer-specific neutralizing antibodies (28, 34). We did not observe significant changes in surface binding of these antibodies by FACS (Fig. 3C and Fig. S5 ). We concluded that the mutations introduced do not affect cellsurface expression and overall Pentamer structure. Consistent with these data, purified Pentamer containing both gL-Cys-144-Ser and UL128-Cys-162-Ser was antigenically equivalent to the WT protein (32) . Together, the interference and syncytia data suggest that mutations of both gL-Cys-144 and UL128-Cys-162 affect Pentamer interaction with host factors and its function in cell entry.
Architecture of gH/gL, gH/gL/gO, Pentamer, and Their Complexes with MSL-109. Structures of gH/gL from EBV and HSV have been described (10, 11) . EBV gH/gL presents an elongated structure in which all of the gH domains are aligned in the same plane (Fig. S6A) . HSV gH/gL, conversely, is organized in a characteristic "boot" shape with a ∼60°kink between domain III and IV at the C terminus of the molecule (Fig. S6B) .
The architecture of HCMV gH/gL was investigated by negative-staining EM and single-particle analysis. To facilitate the EM studies, we analyzed the gH/gL homodimer alone and bound to the fragment antigen-binding (Fab) region of the neutralizing antibody MSL-109. Negative-staining EM 2D class averages revealed that gH/gL forms a symmetrical homodimer, with the N termini providing the main interface for dimerization (Fig. 4A,  Left) . The localization of the dimerization interface is consistent with the involvement of gL-Cys-144 in HCMV gH/gL homodimerization and the location of gL close to the N terminus of gH in the structures of other herpesvirus gH/gLs (9-11). Analysis of the gH/gL/MSL-109 2D class averages revealed the presence of a kink between domain DIII and DIV, suggesting that HCMV gH/gL is more similar to HSV gH/gL than EBV gH/gL (Fig. S6 A  and B) . Finally, a 2D difference map between gH/gL and gH/gL/ MSL-109 confirmed the location of the Fab at the gH/gL "heel" region (Fig. S7A) .
The same boot-like organization and site of binding for MSL-109 was also observed in gH/gL/gO and Pentamer (Fig. 4 B and  C) . Interestingly, 2D analysis of gH/gL/gO and Pentamer alone and in complex with MSL-109 showed that both gO and the ULs bind the N terminus of gH/gL (Fig. 4 B and C) . However, the structural comparison suggests that no major domain rearrangements occur in gH/gL upon binding to either gO or the ULs (Fig. 4 A-C) . This result is supported by surface plasmon resonance (SPR) data demonstrating similar binding affinities of MSL-109 to both gH/gL/gO and Pentamer (Fig. S8) .
We also generated a 3D reconstruction of gH/gL/gO and Pentamer bound to MSL-109 Fab (Fig. 5 A and B) . These complexes adopted a strong preferential view, which required the use of the random conical tilt (RCT) reconstruction technique to guide the fitting of HCMV gH/gL and MSL-109 into the electron density map. Additional electron density emerging from the gH/gL Nterminal region describes the overall shape of the gO and UL128/ UL130/UL131A subunits, respectively (Fig. 5 A and B) . Therefore, gH/gL/gO and Pentamer RCT reconstruction comparisons indicate that the gO and UL subunits interact with a shared surface on gH/gL. This finding is consistent with gL-Cys144 forming an intermolecular disulfide bond in each of the three complexes.
Hydrogen-Deuterium Exchange Coupled to MS Analysis of gH/gL/ MSL-109 Complex. Hydrogen-deuterium exchange coupled to MS (HDX-MS) was used to confirm the EM results and determine the MSL-109 epitope at the amino acid level. The degree of deuterium incorporation into a deglycosylated gH/gL was assessed for several peptides, covering ∼70% of the gH/gL sequence (SI Results; Fig. S9 ). HDX-MS revealed a reduction in deuterium uptake upon binding of MSL-109 for residues 380-396, 400-419, and 400-423. The epitope was narrowed to residues 380-396 and 418-423 by comparing the deuterium uptake of peptides 400-419 and 400-423 with the uptake of peptides 400-416 and 404-417 (Fig. S10 ). An HCMV gH/gL homology (Fig. 5C) . Notably, these peptides are in proximity of escape mutations (W168C/R, P171S/H, and D446N) that were raised by growing HCMV VR1814 virus in epithelial cells (ARPE-19) or fibroblasts (MRC-5) in the presence of suboptimal MSL-109 antibody concentrations (37).
Discussion
We have characterized gH/gL, gH/gL/gO, and Pentamer biochemically, functionally, and structurally and studied their interaction with the human HCMV-neutralizing antibody MSL-109. EM analysis showed that HCMV gH/gL resembles HSV gH/ gL and that gO and the ULs form a protrusion extending from the gH/gL N terminus in gH/gL/gO and Pentamer, respectively (Fig. 6) . Moreover, SDS/PAGE analysis of the purified complexes showed that gO and UL128 form covalent interactions with gL. Surprisingly, MS analysis revealed that the same cysteine, gL-Cys-144, forms disulfide bonds with UL128-Cys-162 in Pentamer and gO-Cys-351 in gH/gL/gO. gL-Cys-144 and UL128-Cys-162 are strictly conserved among all HCMV strains, suggesting a functional role for this disulfide. Together, these data are consistent with gO and the ULs binding to an overlapping site at the N terminus of gH/gL.
Both EM and MS analyses demonstrate that the gH/gL/gO and Pentamer complexes are mutually exclusive. This finding explains why Pentamer and gH/gL/gO form distinct complexes on the virus and/or cell surface (23) . The alternative binding of the ULs and gO to gL-Cys-144 may explain the increase in gH/gL/gO levels on the virus envelope upon suppression of UL128/UL130/UL131A (24) . In addition, our results suggest that HCMV gH/gL might not exist as an independent complex on the viral envelope but is assembled either as gH/gL/gO or Pentamer. This hypothesis is in agreement with recent HCMV strain analyses revealing that only gH/gL/gO and Pentamer are present on the viral envelope (24) .
Previous studies demonstrated that, depending on the producer cells used (i.e., epithelial vs. fibroblasts), the gH/gL/gO: Pentamer ratio on free virions differs, which affects HCMV transmission and tropism (38) . We speculate that HCMV may modulate this ratio through competition between gO and UL128 for gL-Cys-144 binding (Fig. 6) . However, the exact factors (cellular, viral, or both) that influence gO vs. UL128 binding and disulfide formation with gL remain to be determined.
gL-Cys-144 mediates homodimerization of recombinant soluble gH/gL. Formation of these covalent homodimers might be caused by the lack of a biologically relevant binding partner for gL-Cys-144 (i.e., UL128 or gO). It has been recently proposed that gH/gL may form homodimers when on the cellular membrane and that MSL-109 binding affects dimers assembly as judged by FRET (37) . It is unclear at this stage whether these homodimers are the same as those described here for soluble gH/gL.
Pentamer overexpression specifically inhibits HCMV infection of epithelial cells, but not fibroblasts, whereas overexpression of gH/gL/gO interferes with HCMV entry in fibroblasts, but not epithelial/endothelial cells (17, 21) . These data point to the existence of cell-specific entry receptors for gH/gL/gO and Pentamer, respectively. Our low-resolution 3D structures of Pentamer and gH/gL/gO show that gO or UL128 interaction with gH/gL does not cause large conformational changes in gH/ gL. This finding suggests that gO and the ULs are directly involved in receptor binding (i.e., in contrast to new sites being exposed in gH/gL when the latter is in complex with gO or ULs).
Of note, overexpression of the Pentamer gL-Cys-144-Ser/ UL128-Cys-162-Ser double mutant failed to interfere with HCMV entry in ARPE-19 cells, despite normal surface expression levels, whereas the single cysteine mutant behaved similarly to the WT complex. The same double cysteine mutant was unable to allow syncytia formation when coexpressed with gB, presumably through the same mechanism (i.e., impaired binding to a cell surface receptor). Furthermore, the antibody-binding data did not reveal large structural changes in the cysteine mutants. These results together suggest that the mutated cysteines (gL-Cys-144-Ser and UL128-Cys-162-Ser) might be located near a receptor-binding site, which is affected by their simultaneous mutation.
A role for the N-terminal region of gH/gL in receptor binding is consistent with what has been observed in other herpesvirus gH/gLs (39) (40) (41) (42) (43) . In the alpha herpesvirus PrV, a fusion protein in which the ectodomain of the receptor-binding protein gD was fused to the N-terminal region of gH was able to interact with gB for entry, substituting for gD, gH, and gL (44) . A similar solution may have been adopted in HCMV with gO and ULs binding to gH/gL to form complexes that assume the functions of receptor binding and fusion regulation. Similar to HCMV, it has been shown that in HHV-6A, the gQ1/gQ2 components of the tetrameric gH/gL/gQ1/gQ2 complex are directly involved in binding to the entry receptor CD46 (45) .
Highly potent HCMV-neutralizing monoclonal antibodies that bind the Pentamer, but not gH/gL, have been isolated from the memory B-cell repertoire of HCMV immune donors (25, 26) . These antibodies were capable of potently neutralizing HCMV infection of epithelial and endothelial cells, but not fibroblasts. Instead, antibodies binding to both gH/gL and Pentamer have been shown to neutralize HCMV infection in all cell types. However, in epithelial and endothelial cells, antibodies specific to the ULs are much more potent (25, 26) . Our structural data help to rationalize these data and to identify the relative location of two Pentamer regions that are targeted by these different classes of neutralizing antibodies. One region, which involves the gH/gL part of the complexes (in light blue in Fig. 6 ), is structurally conserved in gH/gL/gO, gH/gL, and Pentamer and may play a role in cell-independent steps of the viral fusion process, such as gB binding. The second region is formed by the UL subunits and forms an extension at the gH/gL N terminus. This region likely includes the binding site for the entry receptor for epithelial and endothelial cells (Fig. 6) .
We have recently shown that mice immunized with MF59 adjuvanted Pentamer protein raise high neutralizing antibody titers (32) . These neutralizing responses were comparable to those observed in seropositive subjects and were 4-, 10-, and 90-fold more potent than those obtained with adjuvanted gH/gL in mice, rabbits, and cotton rats, respectively. In addition, analysis of immunized mouse sera revealed that the Pentamer vaccine raised antibodies binding to both gH/gL and to the ULs and that the latter were responsible for most of the neutralization potency of HCMV infection in epithelial and endothelial cells. Therefore, vaccination strategies aimed at targeting the immune response toward the UL-containing region of the Pentamer may prove valuable in raising strong and protective antibody responses.
In conclusion, we have demonstrated that UL128 and gO covalently bind to the same site on gH/gL using the conserved gL-Cys-144 and thus leading to formation of separate complexes on the virus. Both complexes retain the same structural conformation in the gH/gL region as confirmed by antibody binding and EM analysis. Together, these findings will guide the rational design of a new generation of HCMV vaccines with the potential to elicit potent and clinically relevant protective neutralizing antibody responses.
Materials and Methods
Detailed methods are provided in SI Materials and Methods. These describe construct generation and protein expression, purification and characterization, EM analysis, HDX, MS, and interference and syncytia assays.
